Scientists develop a cancer vaccine to kill and prevent deadly brain cancer

Credit: Unsplash+

In a study from Brigham and Women’s Hospital, scientists found developed a new cell therapy approach to eliminate established tumors and induce long-term immunity, training the immune system so that it can prevent cancer from recurring.

The team tested this dual-action, cancer-killing vaccine in an advanced mouse model of the deadly brain cancer glioblastoma, with promising results.

In the study, the team pursued a simple idea: to take cancer cells and transform them into cancer killers and vaccines.

Using gene engineering, they repurposed cancer cells to develop a therapeutic that kills tumor cells and stimulates the immune system to both to destroy primary tumors and prevent cancer.

Cancer vaccines are an active area of research for many labs, but the approach that Shah and his colleagues have taken is distinct.

Instead of using inactivated tumor cells, the team repurposes living tumor cells, which possess an unusual feature.

Like homing pigeons returning to roost, living tumor cells will travel long distances across the brain to return to the site of their fellow tumor cells.

Taking advantage of this unique property, the team engineered living tumor cells using the gene-editing tool CRISPR-Cas9 and repurposed them to release tumor cell killing agents.

In addition, the engineered tumor cells were designed to express factors that would make them easy for the immune system to spot, tag and remember, priming the immune system for a long-term anti-tumor response.

The team tested their new vaccine in different mice strains including the one that bore bone marrow, liver, and thymus cells derived from humans, mimicking the human immune microenvironment.

This dual-action cell therapy was safe, applicable, and efficacious in these models, suggesting a roadmap toward therapy.

While further testing and development are needed, the team specifically chose this model and used human cells to smooth the path of translating their findings for patient settings.

If you care about health, please read studies about how the Mediterranean diet could protect your brain health, and vitamin D supplements could strongly reduce cancer death.

For more information about health, please see recent studies about very strong brain abnormalities post-COVID, and these antioxidants could help reduce dementia risk.

The study was conducted by Khalid Shah et al and published in Science Translational Medicine.

Copyright © 2023 Knowridge Science Report. All rights reserved.